NCT06238960 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Nelson M, Bourke M, Crossley K, Russell T
Telerehabilitation is non-inferior to usual care following total hip replacement - a randomized controlled non-inferiority trial. Physiotherapy. 2020 Jun;107:19-27. doi: 10.1016/j.physio.2019.06.006. Epub 2019 Ju
Sadiq S, Ahmad A, Ahmed A, Khan I, Asim HM, Aziz A
Role of tele-rehabilitation in patients following total hip replacement: Systematic review of clinical trials. J Pak Med Assoc. 2022 Jan;72(1):101-107. doi: 10.47391/JPMA.832.

Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement: Randomized Clinical Trial.

Clinical trial NCT06238960 - References